NASDAQ:ESPR   Esperion Therapeutics, Inc.
ESPR is oversold according To RSi. Looks like it has gapped down to a support area. Billion Dollar company- dont think it will be going broke anytime soon. More than likely they have other products going on. And supposedly the news isnt as bad as it seems. there is a law suit pending which could drive the stock down more. So keep on your watch list.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.